MARKER THERAPEUTICS INC revenue breakdown overview

MARKER THERAPEUTICS INC revenue for the last year amounted to 6.37 M EUR, the most of which — 6.37 M EUR — came from its highest performing source at the moment, Immunotherapies and Innovative Peptide-Based Vaccines, the year earlier bringing 3.00 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought MARKER THERAPEUTICS INC 6.37 M EUR, and the year before that — 3.00 M EUR.